Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Novartis Consumer Health

Novartis Consumer Health Recalls

All product recalls associated with Novartis Consumer Health.

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

1000

Class I (Serious)

127

Most Recent

Jan 2026

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 19821–19840 of 25002 recalls

Maalox Advanced (Novartis) – illegible labeling (2013)

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Class IIILow

FDAAug 6, 2013Nationwide• Novartis Consumer Health

Maalox Extra Strength (Novartis) – illegible labeling (2013)

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Class IIILow

FDAAug 6, 2013Nationwide• Novartis Consumer Health

Benefibre Orange Creme Chewables (Novartis) – illegible packaging (2013)

The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

1...990 991992993 994...1251

Page 992 of 1251Next

Class III

Low

FDAAug 6, 2013Nationwide• Novartis Consumer Health

Maalox Regular Strength (Novartis) – illegible labeling (2013)

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Class IIILow

FDAAug 6, 2013Nationwide• Novartis Consumer Health

Maalox Extra Strength Antacid (Novartis) – Illegible Lot Number (2013)

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Class IIILow

FDAAug 6, 2013Nationwide• Novartis Consumer Health

Maalox Advanced Antacid (Novartis) – Illegible Lot Number (2013)

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Class IIILow

FDAAug 6, 2013Nationwide• Novartis Consumer Health

Maalox Extra Strength (Novartis) – illegible labeling (2013)

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Class IIILow

FDAAug 6, 2013Nationwide• Novartis Consumer Health

Benefiber Fiber Supplement (Novartis) – illegible packaging (2013)

The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Class IIILow

FDAAug 6, 2013Nationwide• Novartis Consumer Health

Benefiber Fiber + Calcium Chewables (Novartis) – illegible packaging (2013)

The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Class IIILow

FDAAug 6, 2013Nationwide• Novartis Consumer Health

Benefiber Orange Creme Chewables (Novartis) – illegible packaging (2013)

The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Class IIILow

FDAAug 6, 2013Nationwide• Novartis Consumer Health

Maalox Regular Strength (Novartis) – illegible labeling (2013)

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Class IIILow

FDAAug 6, 2013Nationwide• Novartis Consumer Health

Benefiber Fruit Chewables (Novartis) – illegible packaging (2013)

The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Class IIILow

FDAAug 6, 2013Nationwide• Novartis Consumer Health

Valacyclovir HCl Tablets (American Health) – Potency Issue (2013)

Subpotent

Class IIModerate

FDAAug 2, 2013Nationwide• American Health Packaging

Benztropine Mesylate Injection (Nexus) – Glass Delamination (2013)

Presence of particulate matter: characterized as thin colorless flakes that are visually and chemically consistent with glass delamination.

Class IIModerate

FDAAug 1, 2013Nationwide• Nexus Pharmaceuticals Inc

B-50 Capsules (Purity First) – Undeclared Steroids (2013)

Undeclared Allergen

Marketed Without An Approved NDA/ANDA: FDA analysis of this product found it to contain undeclared steroids and steroid-like substances making this an unapproved new drug.

Class IHigh

FDAJul 31, 2013CT, IN, NJ +1 more• Healthy Life Chemistry Inc dba Purity First

Multi-Mineral Capsules (Purity First) – Undeclared Steroids (2013)

Undeclared Allergen

Marketed Without An Approved NDA/ANDA: New York State Department of Health analysis of this product found it to contain undeclared steroid-like substances making it an unapproved new drug.

Class IHigh

FDAJul 31, 2013CT, IN, NJ +1 more• Healthy Life Chemistry Inc dba Purity First

Belladonna Alkaloids Tablets (West-Ward) – Foreign Substance (2013)

Presence of Foreign Substance: black specks comprised of degraded organic material found on tablets

Class IIModerate

FDAJul 30, 2013Nationwide• West-Ward Pharmaceutical Corp.

Lisinopril Tablets (West-Ward) – Impurity Specification (2013)

Failed Impurities/Degradation Specifications: Out of Specification results for Individual Other Unknown Related Compounds were obtained at the 48 month time-point.

Class IIModerate

FDAJul 30, 2013Nationwide• West-Ward Pharmaceutical Corp.

Hydrogen Peroxide Injectable (Beacon Hill) – Sterility Risk (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Magnesium Sulfate Injectable (Beacon Hill) – Sterility Doubt (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.